Name: Latest research reports of Ajanta Pharma Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Ajanta Pharma Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Mid-range Performer

2904.7000 -39.20 (-1.33%)

NSE Mar 20, 2026 15:49 PM

New 52W High in past week

Volume: 111.4K

Ajanta Pharma Ltd.

28 Jul 2023

2904.70

-1.33%

Ajanta Pharma (BUY): Q1 beat sparked by sharp margin recovery

Buy: Ajanta Pharma Ltd.

Target

BOB Capital Markets Ltd.

Strong Q1 beat with EBITDA/PAT of Rs 2.7bn/Rs 2.1bn coming in 17%/ 39% ahead of consensus due to margin recovery

Number of FII/FPI investors decreased from 343 to 316 in Dec 2025 qtr